Monoclonal Antibody Combo Therapy Seen to Slow Malignant Mesothelioma Growth in Mice
News
Monoclonal antibodies against CD26 may be a new adjuvant therapy in the treatment of malignant mesothelioma (MM) patients, according to a study published in the journal Cancer Cell International, and titled ... Read more